Stoxline.com
android_stock_chart
Stock Chart

Stoxline Lite

Stoxline Pro

Option Calculator
Stoxline
Mobile

Home | Charts | Showcases | Stock Ranks | Options | ETFs | Educations

 
Tweet this page
Share on Facebook
Share on Google+

7 Binary Options

 

Enter Stock Symbol:  

Taro Pharm Inds (TARO)

111.97 -1.01 (-0.89%)

05-21 16:01

Open:

113.42

Pre. Close:

112.98

High:

113.42

Low:

111.17

Volume:

76,038

Market Cap:

4490M

Stock Price Prediction (Update at 5:00pm est.)

If tomorrow:

Open lower

Open higher

High:

113.537 - 114.156

114.156 - 114.671

Low:

109.655 - 110.434

110.434 - 111.081

Close:

110.794 - 111.985

111.985 - 112.974

Technical analysis  (as of: 2018-05-21 4:33:57 PM)

Overall:

      

Stoxline posted a SELL today, same as yesterday. This stock seems to continue bearish move. So you may continue to hold short positions or sell your long positions. You are relatively safe to short or sell now, downward move is expected.

Target:

Six months: 134.94     One year: 157.61

Support:

Support1: 105.79    Support2: 99.77

Resistance:

Resistance1: 115.53    Resistance2: 134.94

Pivot:

108.31

Moving Averages:

MA(5): 113.15     MA(20): 106.69

MA(100): 102.25     MA(250): 106.57

MACD:

MACD(12,26): 3.29     Signal(12,26,9): 2.60

%K %D:

%K(14,3): 85.05     %D(3): 90.29

RSI:

RSI(14): 67.91

52-Week:

High: 128.46  Low: 93.01  Change(%): 3.8

Average Vol(K):

3-Month: 7885  10-Days 7272

Strong Sell ★★ Sell ★★★ Neutral ★★★★ Buy ★★★★★ Strong Buy

Price, moving averages and Bollinger Bands

Price and moving averages has closed above its Short term moving average. Short term moving average is currently above mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BULLISH in short-term; and BULLISH in mid-long term.
TARO has closed below upper band by 27.8%. Bollinger Bands are 174.4% wider than normal. The large width of the bands suggest high volatility as compared to TARO's normal range. The bands have been in this wide range for 7 bars. This is a sign that the current trend might continue.

Headline News

2018-05-18T22:06:03-04:00
Taro Pharmaceutical's (TARO) CEO Uday Baldota on Q4 2018 Results - Earnings Call Transcript

2018-05-18T10:44:21-04:00
More on Taro Pharmaceutical Q4 results

2018-05-17T18:01:32-04:00
Taro Pharmaceutical reports Q4 results

2018-05-17T17:57:00-04:00
Taro Provides Results for Year Ended March 31, 2018

2018-05-11T15:00:00-04:00
Taro to Announce Full Year Results on May 17, 2018

2018-05-08T15:13:00-04:00
The Acquirer's Portfolio - Large Cap Q2 Update

2018-03-29T07:30:00-04:00
Crescita Announces Launch of Pliaglis in U.S.

2018-03-12T08:38:12-04:00
Premarket analyst action - healthcare

Financial Analysis

Growth

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.

Profitability

Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.

Solvency

Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.

Efficiency

Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.

Click here to get more fundamental analysis.

 

Free Technical Analysis Charts

Stock Basics & Statistics

Sector:  Healthcare

Industry:  Pharmaceuticals

Shares Out. (M)

40.10

Shares Float (M)

40.10

% Held by Insiders

% Held by Institutions

12.20

Shares Short (K)

642

Shares Short Prior Month (K)

1640

Stock Financials

EPS

EPS Est. Current Year

9.490

EPS Est. Next Year

7.990

EPS Est. Next Quarter

Forward EPS

1.#IO

Book Value (p.s.)

1.960

PEG Ratio

Profit Margin

25.41

Operating Margin

48.58

Return on Assets (ttm)

8.9

Return on Equity (ttm)

9.9

Qtrly Rev. Growth

-29.5

Gross Profit (p.s.)

Sales Per Share

EBITDA (p.s.)

Qtrly Earnings Growth

-87.10

Operating Cash Flow (M)

342.88

Levered Free Cash Flow (M)

326.02

atoplab.com

Valuation

P/E

P/E Growth Ratio

P/BV

57.13

P/S

265366256.00

P/CF

13.10

Dividend Yield

Dividends & Splits

Dividend

Dividend Pay Date

Invalid DateTime.

Ex-Dividend Date

Invalid DateTime.

Forward Dividend

Last Split Date

Last Split Ratio

-1e+010

 

(c) 2006-2017 Stoxline.com | Contact us | NYSE, NASDAQ, AMEX Stock symbols

Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.